In a statement issued on June 4, 2023, in Mexico City, the Federal Commission for Protection against Health Risks(COFEPRIS – Federal Commission for the Protection against Sanitary Risks – Regulatory Agency of Mexico) reported that, according to the most recent Biweekly Therapeutic Expansion Report, authorizations have been granted for a total of 179 health inputs, encompassing the categories of drugs, medical devices, and clinical trials. One relevant clinical trial was conducted to evaluate a drug intended for the treatment of acute lymphoblastic leukemia. Read more here:

ELS can help in the investigation and research of all types of medical devices in Europe and LATAM, please contact your local ELS consultant via this link: or via email:

Artigos relacionados

Contact us

call us +351 21 452 50 38

Send us a message

We will contact you as soon as possible.